S
SOLENO THERAPEUTICS INC
NASDAQ: SLNO (Soleno Therapeutics, Inc.)
Last update: 16 hours ago86.65
0.44 (0.51%)
| Previous Close | 86.21 |
| Open | 86.12 |
| Volume | 330,112 |
| Avg. Volume (3M) | 1,006,252 |
| Market Cap | 4,366,631,424 |
| Price / Book | 18.80 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 |
| Diluted EPS (TTM) | -4.74 |
| Total Debt/Equity (MRQ) | 22.73% |
| Current Ratio (MRQ) | 19.64 |
| Operating Cash Flow (TTM) | -89.32 M |
| Levered Free Cash Flow (TTM) | -33.98 M |
| Return on Assets (TTM) | -52.40% |
| Return on Equity (TTM) | -105.54% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Soleno Therapeutics, Inc. | Bearish | Bullish |
AIStockmoo Score
-0.4
| Analyst Consensus | 1.0 |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.40 |
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 1.89% |
| % Held by Institutions | 112.43% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 145.00 (Piper Sandler, 67.34%) | Buy |
| Median | 102.50 (18.29%) | |
| Low | 97.00 (Guggenheim, 11.95%) | Buy |
| Average | 111.75 (28.97%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 74.25 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 08 May 2025 | 105.00 (21.18%) | Buy | 76.26 |
| Guggenheim | 08 May 2025 | 97.00 (11.94%) | Buy | 76.26 |
| Piper Sandler | 24 Apr 2025 | 145.00 (67.34%) | Buy | 74.23 |
| HC Wainwright & Co. | 15 Apr 2025 | 100.00 (15.41%) | Buy | 70.25 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HIRANO PATRICIA C | - | 83.40 | -4,096 | -338,862 |
| Aggregate Net Quantity | -4,096 | |||
| Aggregate Net Value ($) | -338,862 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 83.40 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HIRANO PATRICIA C | Officer | 01 Jul 2025 | Automatic sell (-) | 3,830 | 82.63 | 316,473 |
| HIRANO PATRICIA C | Officer | 24 Jun 2025 | Automatic sell (-) | 266 | 84.17 | 22,389 |
| HIRANO PATRICIA C | Officer | 24 Jun 2025 | Option execute | 266 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |